Cite Filings / OBX
Feed Companies Filings Check
Sign in

CIK 0002130606 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Obsidian Therapeutics, Inc.

Sign in to watch
Ticker
OBX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
421977778
Phone
(781) 806-6245
Business address
1030 MASSACHUSETTS AVENUE, CAMBRIDGE, MA, 02138
Former names
Gazelle Parent, Inc.
Filings Insiders Search text
All 38 Financials 5 Executive Compensation 3 Insider Trading 14 Beneficial Ownership Interest 5 Business Combinations 8 Public Offerings 3 Others 6
›
Filed in
  1. No filings match these filters. Clear filters
  2. 4 Insider Changes in Ownership 2026-08-05
  3. 4 Insider Changes in Ownership 2026-08-05
  4. 4 Insider Changes in Ownership 2026-08-05
  5. 4 Insider Changes in Ownership 2026-08-05
  6. 4 Insider Changes in Ownership 2026-08-05
  7. 4 Insider Changes in Ownership 2026-08-05
  8. 3 Insider Initial Statement of Ownership 2026-08-03
  9. 3 Insider Initial Statement of Ownership 2026-08-03
  10. 3 Insider Initial Statement of Ownership 2026-08-03
  11. 3 Insider Initial Statement of Ownership 2026-08-03
  12. 3 Insider Initial Statement of Ownership 2026-08-03
  13. 3 Insider Initial Statement of Ownership 2026-08-03
  14. 3 Insider Initial Statement of Ownership 2026-08-03
  15. 3 Insider Initial Statement of Ownership 2026-08-03

Page 1 of 1 · 14 filings

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…